Fluorescent protein-based tumor models

In Vivo

Volumn 26, Issue 4, 2012, Pages 599-608

  Yagublu, V ^a,b   Ahmadova, Z ^a   Hafner, M ^c,d   Keese, Michael ^a,e  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Scientific Center of Surgery   (Azerbaijan)

^c MANNHEIM UNIVERSITY OF APPLIED SCIENCES   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Biosensor; Fluorescence; FRET; GFP; Review; Tumor model

Indexed keywords

CASPASE 3; FLUOROURACIL; GREEN FLUORESCENT PROTEIN;

ANGIOGENESIS; ANTHOZOA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER INVASION; CANCER THERAPY; CELL CULTURE; CELL INTERACTION; CELL MIGRATION; COLON CARCINOMA; COST EFFECTIVENESS ANALYSIS; EXPERIMENTAL ANIMAL; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; HAMSTER; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; JELLYFISH; LIVER METASTASIS; MONOLAYER CULTURE; NONHUMAN; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SARCOMA; TISSUE CULTURE; TUMOR GROWTH; TUMOR MODEL; TUMOR XENOGRAFT; ANIMAL; DISEASE COURSE; EXPERIMENTAL NEOPLASM; HUMAN; METABOLISM; PATHOLOGY;

ANIMALS; DISEASE PROGRESSION; GREEN FLUORESCENT PROTEINS; HUMANS; NEOPLASMS, EXPERIMENTAL;

EID: 84865080014     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Stock CC, Reilly HC, Buckley SM, Clarke DA and Rhoads CP: Azaserine, a new tumour-inhibitory substance; studies with Crocker mouse sarcoma 180. Nature 173: 71-72, 1954.
2. Maltman DJ and Przyborski SA: Developments in three-dimensional cell culture technology aimed at improving the accuracy of in vitro analyses. Biochem Soc Trans 38: 1072-1075, 2010.
3. Brown JM and Giaccia AJ: The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416, 1998. (Pubitemid 28193601)
4. Burchill SA: What do, can and should we learn from models to evaluate potential anticancer agents? Future Oncol 2: 201-211, 2006.
5. Yamada KM and Cukierman E: Modeling tissue morphogenesis and cancer in 3D. Cell 130: 601-610, 2007. (Pubitemid 47268064)
6. Staton CA, Stribbling SM, Tazzyman S, Hughes R, Brown NJ and Lewis CE: Current methods for assaying angiogenesis in vitro and in vivo . Int J Exp Pathol 85: 233-248, 2004. (Pubitemid 39319155)
7. Vailhe B, Vittet D and Feige JJ: In vitro models of vasculogenesis and angiogenesis. Lab Invest 81: 439-452, 2001. (Pubitemid 32298789)
8. Nguyen M, Shing Y and Folkman J: Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 47: 31-40, 1994. (Pubitemid 24194854)
9. Ausprunk DH, Knighton DR and Folkman J: Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels. Am J Pathol 79: 597-618, 1975.
10. Griswold DP Jr. and Harrison SD Jr.: Tumor models in drug development. Cancer Metastasis Rev 10: 255-261, 1991.
11. Sporn MB and Liby KT: Cancer chemoprevention: scientific promise, clinical uncertainty. Nat Clin Pract Oncol 2: 518-525, 2005. (Pubitemid 41553936)
12. Darro F, Decaestecker C, Gaussin JF, Mortier S, Van Ginckel R and Kiss R: Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? Int J Oncol 27: 607-616, 2005.
13. Teicher BA: Tumor models for efficacy determination. Mol Cancer Ther 5: 2435-2443, 2006.
14. Hanahan D: Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315: 115-122, 1985.
15. Peterson JK and Houghton PJ: Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development. Eur J Cancer 40: 837-844, 2004. (Pubitemid 38519762)
16. Rygaard J and Povlsen CO: Heterotransplantation of a human malignant tumour to "Nude" mice. Acta Pathol Microbiol Scand 77: 758-760, 1969.
17. Sturm JW, Keese MA, Petruch B, Bonninghoff RG, Zhang H, Gretz N, Hafner M, Post S and McCuskey RS: Enhanced green fluorescent protein-transfection of murine colon carcinoma cells: key for early tumor detection and quantification. Clin Exp Metastasis 20: 395-405, 2003. (Pubitemid 37108425)
18. Kruger A, Umansky V, Rocha M, Hacker HJ, Schirrmacher V and von Hoegen P: Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphoma. Blood 84: 3166-3174, 1994. (Pubitemid 24328111)
19. Ghossein RA, Bhattacharya S and Rosai J: Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 5: 1950-1960, 1999. (Pubitemid 29399243)
20. Ho SB, Hyslop A, Albrecht R, Jacobson A, Spencer M, Rothenberger DA, Niehans GA, D'Cunha J and Kratzke RA: Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen. Clinical cancer research: an official journal of the American Association for Cancer Research 10: 5777-5784, 2004.
21. Chudakov DM, Matz MV, Lukyanov S and Lukyanov KA: Fluorescent proteins and their applications in imaging living cells and tissues. Physiol Rev 90: 1103-1163, 2010.
22. Zhang J, Campbell RE, Ting AY and Tsien RY: Creating new fluorescent probes for cell biology. Nat Rev Mol Cell Biol 3: 906-918, 2002. (Pubitemid 35477369)
23. Drobizhev M, Makarov NS, Tillo SE, Hughes TE and Rebane A: Two-photon absorption properties of fluorescent proteins. Nature methods 8: 393-399, 2011.
24. Chishima T, Miyagi Y, Wang X, Yamaoka H, Shimada H, Moossa AR and Hoffman RM: Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res 57: 2042-2047, 1997. (Pubitemid 27209739)
25. Hoffman RM: The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 5: 796-806, 2005.
26. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A and Muschel RJ: Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 6: 100-102, 2000. (Pubitemid 30048535)
27. Hayashi K, Kimura H, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Kishimoto H, Hasegawa A, Bouvet M and Hoffman RM: Comparison of cancer-cell seeding, viability and deformation in the lung, muscle and liver, visualized by subcellular real-time imaging in the live mouse. Anticancer Res 31: 3665-3672, 2011.
28. Suetsugu A, Katz M, Fleming J, Truty M, Thomas R, Saji S, Moriwaki H, Bouvet M and Hoffman RM: Imageable Fluorescent Metastasis Resulting in Transgenic GFP Mice Orthotopically Implanted with Human-patient Primary Pancreatic Cancer Specimens. Anticancer Res 32: 1175-1180, 2012.
29. Zhou W, Zhu H, Chen W, Hu X, Pang X, Zhang J, Huang X, Fang B and He C: Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus. Cancer Gene Ther 18: 336-345, 2011.
30. Keese M, Gasimova L, Schwenke K, Yagublu V, Shang E, Faissner R, Lewis A, Samel S and Lohr M: Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer. International journal of cancer. Journal international du cancer 124: 2701-2708, 2009.
31. Prevarskaya N, Skryma R and Shuba Y: Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 11: 609-618, 2011.
32. Choi KR, Berrera M, Reischl M, Strack S, Albrizio M, Roder IV, Wagner A, Petersen Y, Hafner M, Zaccolo M and Rudolf R: Rapsyn mediates subsynaptic anchoring of PKA type I and stabilisation of acetylcholine receptor in vivo . J Cell Science 125: 714-723, 2012.
33. Rudolf R, Hafner M and Mongillo M: Investigating second messenger signaling in vivo . Methods in enzymology 505: 363-382, 2012.
34. Keese M, Offterdinger M, Tischer C, Girod A, Lommerse PH, Yagublu V, Magdeburg R and Bastiaens PI: Quantitative imaging of apoptosis commitment in colorectal tumor cells. Differentiation 75: 809-818, 2007. (Pubitemid 350086165)
35. Keese M, Yagublu V, Schwenke K, Post S and Bastiaens P: Fluorescence lifetime imaging microscopy of chemotherapy-induced apoptosis resistance in a syngenic mouse tumor model. International journal of cancer. J International du Cancer 126: 104-113, 2010.
36. Heim R and Tsien RY: Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol 6: 178-182, 1996.
37. Welsh DK and Kay SA: Bioluminescence imaging in living organisms. Curr Opin Biotechnol 16: 73-78, 2005. (Pubitemid 40249761)
38. Funovics M, Weissleder R and Tung CH: Protease sensors for bioimaging. Anal Bioanal Chem 377: 956-963, 2003. (Pubitemid 40877826)
39. Goedhart J, von Stetten D, Noirclerc-Savoye M, Lelimousin M, Joosen L, Hink MA, van Weeren L, Gadella TW Jr. and Royant A: Structure-guided evolution of cyan fluorescent proteins towards a quantum yield of 93%. Nat Commun 3: 751, 2012.
40. Rhee JM, Pirity MK, Lackan CS, Long JZ, Kondoh G, Takeda J and Hadjantonakis AK: In vivo imaging and differential localization of lipid-modified GFP-variant fusions in embryonic stem cells and mice. Genesis 44: 202-218, 2006. (Pubitemid 43727743)
41. Chen Y, Mills JD and Periasamy A: Protein localization in living cells and tissues using FRET and FLIM. Differentiation 71: 528-541, 2003. (Pubitemid 38091095)
42. Bastiaens PI and Squire A: Fluorescence lifetime imaging microscopy: spatial resolution of biochemical processes in the cell. Trends Cell Biol 9: 48-52, 1999. (Pubitemid 29151791)
43. Goedhart J, van Weeren L, Hink MA, Vischer NO, Jalink K and Gadella TW Jr.: Bright cyan fluorescent protein variants identified by fluorescence lifetime screening. Nat Methods 7: 137-139, 2010.
44. Muller-Taubenberger A and Anderson KI: Recent advances using green and red fluorescent protein variants. Appl Microbiol Biotechnol 77: 1-12, 2007. (Pubitemid 47573310)